YU79202A - Peptid koji modulira trombopoetinski receptor - Google Patents

Peptid koji modulira trombopoetinski receptor

Info

Publication number
YU79202A
YU79202A YU79202A YUP79202A YU79202A YU 79202 A YU79202 A YU 79202A YU 79202 A YU79202 A YU 79202A YU P79202 A YUP79202 A YU P79202A YU 79202 A YU79202 A YU 79202A
Authority
YU
Yugoslavia
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
YU79202A
Other languages
English (en)
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva Farmaceutska Industrija Dioničarsko Društvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Industrija Dioničarsko Društvo filed Critical Pliva Farmaceutska Industrija Dioničarsko Društvo
Publication of YU79202A publication Critical patent/YU79202A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ovaj pronalazak se odnosi na nove dijagnostičke i farmaceutske kompozicije koje omogućuju tretman trombocitopenije.[The present invention relates to novel diagnostic and pharmaceutical compositions enabling the treatment of thrombocytopenia.
YU79202A 2000-04-25 2001-04-23 Peptid koji modulira trombopoetinski receptor YU79202A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
YU79202A true YU79202A (sh) 2006-01-16

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
YU79202A YU79202A (sh) 2000-04-25 2001-04-23 Peptid koji modulira trombopoetinski receptor

Country Status (24)

Country Link
US (1) US20030181659A1 (sh)
EP (2) EP1149906A1 (sh)
JP (1) JP2003530867A (sh)
KR (1) KR20030009450A (sh)
CN (1) CN1426467A (sh)
AR (1) AR030278A1 (sh)
AU (2) AU2001267366B9 (sh)
BG (1) BG107214A (sh)
BR (1) BR0110383A (sh)
CA (1) CA2407167A1 (sh)
CZ (1) CZ20023517A3 (sh)
EA (1) EA006423B1 (sh)
EE (1) EE200200610A (sh)
GE (1) GEP20063763B (sh)
HU (1) HUP0300559A3 (sh)
IL (1) IL152204A0 (sh)
IS (1) IS6582A (sh)
MX (1) MXPA02010458A (sh)
NO (1) NO20025114L (sh)
PL (1) PL358304A1 (sh)
SK (1) SK15262002A3 (sh)
WO (1) WO2001080873A2 (sh)
YU (1) YU79202A (sh)
ZA (1) ZA200208662B (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508173A (ja) * 2001-11-07 2005-03-31 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ２３２、２０５９、１０６３０、１２８４８、１３８７５、１４３９５、１４６１８、１７６９２または５８８７４を使用する血液障害を処置するための方法および組成物
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
EA010759B1 (ru) * 2002-09-18 2008-10-30 Орто-Макнейл Фармасьютикал, Инк. Способы увеличения продукции тромбоцитов и гематопоэтических стволовых клеток
BR0317237A (pt) 2002-12-11 2005-11-01 Ferrosan As Dispositivo para amostragem ou coleta, kit, usos de um dispositivo e de um kit, e, métodos para diminuir a quantidade de um marcador em uma área de amostra, para amostrar de modo qualitativo ou quantitativo uma área quanto ao teor de um marcador e para cultivar microorganismos ou células de mamìferos coletados
EP2336162A1 (en) * 2003-05-12 2011-06-22 Affymax, Inc. Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
MXPA05012314A (es) * 2003-05-12 2006-04-18 Affymax Inc Radical separador para peptido modificado con polietilenglicol.
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
AR054637A1 (es) 2004-01-30 2007-07-11 Ferrosan As Aerosoles y composiciones hemostaticas
RU2369408C2 (ru) 2004-07-09 2009-10-10 Ферросан А/С Гемостатическая композиция, включающая гиалуроновую кислоту
CN101374956B (zh) * 2006-01-31 2014-01-01 三菱化学美迪恩斯株式会社 弥漫性血管内凝血综合征的病态鉴定方法
JP5569398B2 (ja) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー／エス 止血および／または創傷治癒を促進するための装置
EP2708597B1 (en) * 2011-05-13 2017-11-15 The University of Tokyo Polynucleated megakaryocytic cell and method for manufacturing platelets
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
CA2912357C (en) 2013-06-21 2019-12-31 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
RU2678592C1 (ru) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Сухая композиция, содержащая компонент, улучшающий экструзию
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス 止血および創傷治癒に使用するための乾燥組成物
CA2970710A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
EP3316930B1 (en) 2015-07-03 2019-07-31 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2019215274A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
EP1064015A2 (en) * 1998-02-24 2001-01-03 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
JP2003530867A (ja) 2003-10-21
MXPA02010458A (es) 2003-06-06
EA006423B1 (ru) 2005-12-29
WO2001080873A3 (en) 2002-01-31
BR0110383A (pt) 2003-01-21
HUP0300559A3 (en) 2005-09-28
EP1278849A2 (en) 2003-01-29
IL152204A0 (en) 2003-05-29
NO20025114L (no) 2002-12-18
GEP20063763B (en) 2006-03-10
AU2001267366B9 (en) 2005-07-14
SK15262002A3 (sk) 2003-05-02
HUP0300559A2 (hu) 2003-06-28
EE200200610A (et) 2004-08-16
NO20025114D0 (no) 2002-10-24
EA200201138A1 (ru) 2003-06-26
AR030278A1 (es) 2003-08-20
US20030181659A1 (en) 2003-09-25
AU6736601A (en) 2001-11-07
CZ20023517A3 (cs) 2003-10-15
EP1149906A1 (en) 2001-10-31
CN1426467A (zh) 2003-06-25
AU2001267366B2 (en) 2005-06-30
PL358304A1 (en) 2004-08-09
KR20030009450A (ko) 2003-01-29
WO2001080873A2 (en) 2001-11-01
BG107214A (bg) 2003-11-28
CA2407167A1 (en) 2001-11-01
ZA200208662B (en) 2003-10-27
IS6582A (is) 2002-10-14

Similar Documents

Publication Publication Date Title
YU79202A (sh) Peptid koji modulira trombopoetinski receptor
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
MXPA02006028A (es) Lipopeptidos novedosos como agentes antibacterianos.
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
AU3652102A (en) Compounds and their uses
IL151313A0 (en) Lipase containing pharmaceutical compositions
GB0129260D0 (en) Pharmaceutical compositions and their uses
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
BR9711306A (pt) Amino a-Úcar citotÄxico e derivados de a-Úcar correlatos de indolopirrolocarbazÄis
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
TNSN04206A1 (en) Novel perindopril salt and pharmaceutical compositions containing same
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
MXPA03010158A (es) Sulfonamidas.
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
RS20050649A (en) Antibacterial indolone oxazolidinones,intermediates for their preparation and pharmaceutical compositions containing them
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
ATE305517T1 (de) Neurotrypsin
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.